Patents by Inventor Evgenia Lozinsky
Evgenia Lozinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190142910Abstract: Methods for wound debridement and specifically methods of debridement of chronic wounds. These methods provide topically applying to a wound site a debriding formulation in the form of a hydrogel that includes a proteolytic enzyme mixture obtained from bromelain and a water-soluble gelling agent, with the debriding formulation being applied to the wound site up to ten times over a period of up to four weeks, thereby achieving debridement of chronic wounds.Type: ApplicationFiled: January 30, 2017Publication date: May 16, 2019Inventors: Evgenia LOZINSKY, Dafna GEBLINGER, Deborah Hanah BARTFELD, Eilon ASCULAI
-
Publication number: 20180344743Abstract: A topical anorectal or genital composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal or genital surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: ApplicationFiled: August 10, 2018Publication date: December 6, 2018Inventors: Evgenia Lozinsky, Eran Eilat
-
Patent number: 10085994Abstract: A topical composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to a body surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: GrantFiled: March 10, 2014Date of Patent: October 2, 2018Assignee: PeriTech Pharma Ltd.Inventors: Evgenia Lozinsky, Eran Eilat
-
Patent number: 10085995Abstract: A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water, and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: GrantFiled: June 16, 2015Date of Patent: October 2, 2018Assignee: PeriTech Pharma Ltd.Inventors: Evgenia Lozinsky, Eran Eilat
-
Patent number: 9789106Abstract: The present invention relates a foamable otic pharmaceutical compositions comprising oil-in water emulsions which comprise an antibiotic agent and a propellant gas. The pharmaceutical compositions are administered to the ear as foam for treating ear disorders.Type: GrantFiled: December 20, 2016Date of Patent: October 17, 2017Assignee: OTIC PHARMA LTD.Inventors: Evgenia Lozinsky, Yanna Galibov, Rodrigo Yelin
-
Publication number: 20170105991Abstract: The present invention relates a foamable otic pharmaceutical compositions comprising oil-in water emulsions which comprise an antibiotic agent and a propellant gas. The pharmaceutical compositions are administered to the ear as foam for treating ear disorders.Type: ApplicationFiled: December 20, 2016Publication date: April 20, 2017Inventors: Evgenia LOZINSKY, Yanna GALIBOV, Rodrigo YELIN
-
Patent number: 9561240Abstract: The present invention relates to foamable otic pharmaceutical compositions comprising oil-in-water emulsions which comprise an antibiotic agent and a propellant gas. The pharmaceutical compositions are administered to the ear as foam for treating ear disorders.Type: GrantFiled: December 26, 2013Date of Patent: February 7, 2017Assignee: OTIC PHARMA LTD.Inventors: Evgenia Lozinsky, Yanna Galibov, Rodrigo Yelin
-
Publication number: 20150366798Abstract: The present invention provides liquid adhesive compositions including at least one silicone resin film forming agent, at least one surfactant, at least one volatile solvent, water and at least one vasoconstrictor, where the compositions are in the form of an emulsion. The invention further provides methods for treating any type of nose bleeding, including Epistaxis, including administering the liquid adhesive compositions to the nose, in the affected nostril. Further provided is a kit, including the liquid adhesive composition and a container-applicator device.Type: ApplicationFiled: May 1, 2015Publication date: December 24, 2015Inventors: Evgenia Lozinsky, Eran Eilat
-
Publication number: 20150342965Abstract: The present invention relates to foamable otic pharmaceutical compositions comprising oil-in-water emulsions which comprise an antibiotic agent and a propellant gas. The pharmaceutical compositions are administered to the ear as foam for treating ear disorders.Type: ApplicationFiled: December 26, 2013Publication date: December 3, 2015Applicant: OTIC PHARMA LTD.Inventors: Evgenia LOZINSKY, Yanna GALIBOV, Rodrigo YELIN
-
Publication number: 20150272957Abstract: A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water, and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: ApplicationFiled: June 16, 2015Publication date: October 1, 2015Inventors: Evgenia Lozinsky, Eran Eilat
-
Publication number: 20150231300Abstract: The present invention provides liquid adhesive compositions comprising a silicone film forming agent, a volatile solvent and a pharmaceutically active agent, and methods for preparing said compositions. The invention further provides methods for treating anorectal disorders comprising administering the liquid adhesive compositions to the mucous anal surface, kits comprising the liquid adhesive composition and a container-applicator device.Type: ApplicationFiled: October 27, 2013Publication date: August 20, 2015Inventors: Evgenia Lozinsky, Eran Eilat
-
Patent number: 9072747Abstract: A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water; and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: GrantFiled: March 10, 2014Date of Patent: July 7, 2015Assignee: PERITECH PHARMA LTD.Inventors: Evgenia Lozinsky, Eran Eilat
-
Publication number: 20140255521Abstract: A topical composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to a body surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: ApplicationFiled: March 10, 2014Publication date: September 11, 2014Applicant: PeriTech Pharma Ltd.Inventors: Evgenia Lozinsky, Eran Eilat
-
Publication number: 20140255522Abstract: A topical anorectal or genital composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water, and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal or genital surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: ApplicationFiled: March 10, 2014Publication date: September 11, 2014Applicant: PeriTech Pharma Ltd.Inventors: Evgenia Lozinsky, Eran Eilat
-
Publication number: 20140256688Abstract: A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water; and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: ApplicationFiled: March 10, 2014Publication date: September 11, 2014Inventors: Evgenia Lozinsky, Eran Eilat